In the first nine months of 2021, a record 15 digital health companies have gone public (4 SPACs and 11 IPOs) compared to six in
Sema4 Goes Public via SPAC Deal
Sema4, a patient-centered healthcare data analytics company, announced the completion of its business combination with CM Life Sciences, a special purpose acquisition company (SPAC) sponsored
Owlet Baby Care Starts Trading on NYSE After Closing SPAC Deal
Owlet Baby Care, a maker of smart wearable sock that monitors baby’s skin temperature, oxygen levels, and heart rate during sleep and sends relevant data
Heartflow Plans IPO via $2.4 Billion SPAC Deal
HeartFlow, a precision heart care platform, and Longview Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, announced that
Pear Therapeutics To Go Public in a $1.6 Billion SPAC Deal
Pear Therapeutics, a prescription digital therapeutics (PDTs) company delivering solutions for patients, clinicians, and payers, entered into a definitive business combination agreement with Thimble Point
Telehealth Company Babylon To Go Public via $4.2 Billion SPAC Deal
British telehealth company Babylon has agreed to go public in the United States via a merger deal with Alkuri Global Acquisition Corp (Alkuri Global), a
Better Therapeutics Plans to Go Public in a SPAC Deal
Better Therapeutics, a prescription digital therapeutics (PDT) company, announced plans to go public by merging with special purpose acquisition company Mountain Crest Acquisition Corp II.
Owlet Baby Care Plans to Go Public in Yet Another SPAC Deal
Owlet Baby Care, a maker of smart wearable sock that monitors baby’s skin temperature, oxygen levels, and heart rate during sleep and sends relevant data
Sharecare to go Public by Merging With Falcon Capital Acquisition Corporation a SPAC
Sharecare, a virtual health platform that helps people manage all of their health in one place, and Falcon Capital Acquisition Corporation, a special purpose acquisition
Sema4 to Merge with SPAC Company CM Life Sciences
Sema4, a patient-centered healthcare data analytics company, and CM Life Sciences, a special purpose acquisition company (SPAC), sponsored by affiliates of Casdin Capital and Corvex